Efficacy and Safety Results of a Phase 1 Study of 177lu-DOTA-HH1 (Betalutin®) with and without HH1 Pre-Dosing for Patients with Relapsed CD37+ Non-Hodgkin B Cell Lymphoma (NHL)

Autor: Kolstad, Arne, Madsbu, Ulf, Bolstad, Bjørg, Stokke, Caroline, Bach-Gansmo, Tore, Muftuler Løndalen, Ayca, Holtedahl, Jon Erik, Revheim, Mona Elisabeth, Bruland, Øyvind, Dahle, Jostein, Bolstad, Nils, Hartvig Larsen, Roy, Spetalen, Signe, Erlanson, Martin, Nygaard Rudå, Stine, Holte, Harald
Zdroj: Blood; December 2015, Vol. 126 Issue: 23 p5118-5118, 1p
Abstrakt: Background:
Databáze: Supplemental Index